Bone marrow engraftment efficiency is enhanced by competitive inhibition of the hepatic asialoglycoprotein receptor.

Receptor - Specific Inhibition of Bone Marrow

lnterleukin-2 (IL-2) induces differential secretion of lymphokines by li-2 receptor (li-2R)-positive and lL-2Rnegative T cells. We studied T cell lL-2R-specific modulation of adult bone marrow erythropoiesis by recombinant lL-2 (rli-2). li-2R were induced by CD3 T cell surface determinant-triggering and analyzed by cytofluorography. Bone marrow monocyte and T cell-depleted (NAB-T) target cells ...

Receptor - Specific Inhibition of Bone Marrow Erythropoiesis by Recombinant DNA

lnterleukin-2 (IL-2) induces differential secretion of lymphokines by li-2 receptor (li-2R)-positive and lL-2Rnegative T cells. We studied T cell lL-2R-specific modulation of adult bone marrow erythropoiesis by recombinant lL-2 (rli-2). li-2R were induced by CD3 T cell surface determinant-triggering and analyzed by cytofluorography. Bone marrow monocyte and T cell-depleted (NAB-T) target cells ...

Failure Marrow Transplantation after Engraftment Promotes Engraftment for Secondary Bone Primary Bone Marrow Transplantation

The Role of Bone Marrow Aspiration and Bone Marrow Biopsy in Diagnosis of Bone Marrow Metastases

Background: Bone marrow is the site of many malignant disorders and it is one of the common places for solid tumors to metastasize. Examination of the bone marrow aspirate and biopsy is a routine procedure performed for assessment of various conditions such as cytopenias, hematologic neoplasms, nonmalignant disorders and metastatic neoplasms. Methods: The patients were referred to the Hema...

Bone Marrow Transplant (BMT) is the Main Cureavailable for Thalassamia

Introduction: The thalassamias refer to a diverse group of hemoglobin disorders characterized by a reduced synthesis of  one or more of globin chains (α,β, γ, δβ,γδβ, δ and εγδβ).The main cure available today for thalassamia is bone marrow transplantation (BMT)  from compatible donor.On December 3, 1981 a 14-month-old child with β-thalassemia major recieved BMT from his HLA-identical sister in...